Recent studies have focused on tests that can detect HCC, including tests for DCP, also known as prothrombin induced by vitamin K absence II (PIVKA II), the ratio of glycosylated AFP (L3 fraction) to total AFP, alpha fucosidase, glypican 3, and HSP-70. This evidence concerns the gene AFP and hepatocellular carcinoma.